Education
About Us
Working with TipRanks
Follow Us
Orasure (OSUR)
:OSUR
OSUR Stock Chart & Stats
$3.04
-$0.09(-2.38%)
At close: 4:00 PM EST
$3.04
-$0.09(-2.38%)
Day’s Range― - ―
52-Week Range$2.36 - $4.60
Previous CloseN/A
Volume226.53K
Average Volume (3M)490.31K
Market Cap
$200.40M
Enterprise Value$3.17M
Total Cash (Recent Filing)$234.58K
Total Debt (Recent Filing)$14.13M
Price to Earnings (P/E)―
Beta0.83
Next Earnings
Nov 05, 2025EPS Estimate
-0.19Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.26
Shares Outstanding73,136,986
10 Day Avg. Volume525,184
30 Day Avg. Volume490,307
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)0.65
Price to Sales (P/S)1.45
P/FCF Ratio11.40
Enterprise Value/Market Cap0.02
Enterprise Value/Revenue0.08
Enterprise Value/Gross Profit0.07
Enterprise Value/Ebitda-0.07
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Orasure Technologies News
OSUR FAQ
What was Orasure’s price range in the past 12 months?
Orasure lowest stock price was $2.36 and its highest was $4.60 in the past 12 months.
What is Orasure’s market cap?
Orasure’s market cap is $200.40M.
When is Orasure’s upcoming earnings report date?
Orasure’s upcoming earnings report date is Nov 05, 2025 which is tomorrow.
How were Orasure’s earnings last quarter?
Orasure released its earnings results on Aug 05, 2025. The company reported -$0.26 earnings per share for the quarter, missing the consensus estimate of -$0.205 by -$0.055.
Is Orasure overvalued?
According to Wall Street analysts Orasure’s price is currently Overvalued.
Does Orasure pay dividends?
Orasure does not currently pay dividends.
What is Orasure’s EPS estimate?
Orasure’s EPS estimate is -0.19.
How many shares outstanding does Orasure have?
Orasure has 73,136,986 shares outstanding.
What happened to Orasure’s price movement after its last earnings report?
Orasure reported an EPS of -$0.26 in its last earnings report, missing expectations of -$0.205. Following the earnings report the stock price went down -8.333%.
Which hedge fund is a major shareholder of Orasure?
Currently, no hedge funds are holding shares in OSUR
Orasure Technologies Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
OSUR Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 369.9K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-32.59%
12-Months-Change
Fundamentals
Return on Equity
-12.65%
Trailing 12-Months
Asset Growth
-4.57%
Trailing 12-Months
Company Description
Orasure
Orasure Technologies, Inc. is a leading provider of oral fluid diagnostic products, specializing in the development, manufacture, and marketing of innovative medical devices and testing solutions. The company primarily operates in the healthcare sector, focusing on infectious disease testing, drug testing, and molecular diagnostics. Its core products include the OraQuick® rapid HIV test and the Intercept® oral fluid collection device, which are designed for ease of use and accuracy in various clinical and non-clinical settings.
OSUR Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented several highlights, including the successful launch of the HEMAcollect PROTEIN product and a strong cash position. However, these were offset by significant challenges, such as disruptions in international diagnostics and a decline in Sample Management revenue. The uncertainty in U.S. Diagnostics further balanced the positive developments.View all OSUR earnings summariesTechnical Analysis
Ownership Overview
4.83% Insiders
18.55% Mutual Funds
0.27% Other Institutional Investors
64.03% Public Companies and
Individual Investors